Analyst stock forecast
NovoCure Forecast: $27.14 Analyst Target
Direct answer
NovoCure's average price target is $27.14.
The target implies +71.5% from the recorded current price, and the consensus rating is none.
The low target implies +7.4%, the high target implies +228.5%, and the range spans 221.1% of the current price.
Forecast evidence checked September 28, 2026.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $15.83
- Average price target
- $27.14
- High price target
- $52.00
- Low price target
- $17.00
- Low target gap
- +7.4%
- Target upside
- +71.5%
- High target gap
- +228.5%
- Target range width
- 221.1%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- September 28, 2026
- Valid through
- October 5, 2026
Explore related company data
Read the frequently asked questions.
What is NovoCure's average price target?
NovoCure's verified average price target is $27.14. The target range is $17.00 to $52.00.
How far are NovoCure's low and high targets from the recorded price?
The low target implies +7.4%, while the high target implies +228.5%.
How many analysts are included in NovoCure's consensus?
The verified consensus includes 7 analysts.
How is NovoCure's target upside or downside calculated?
The average target of $27.14 is divided by the recorded price of $15.83, then one is subtracted to produce +71.5%. This does not guarantee a future return.
When was NovoCure's analyst forecast verified?
The data was verified on 2026-09-28. The dataset is valid through 2026-10-05.